Chief Executive Officer Craig Parker used a discussion at a 2026 investor summit to outline the company’s focus on Wnt pathway biology and antibody engineering, with an emphasis on retinal vascular ...

Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to ...

A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade ...

A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Discover how saliva testing detects oral and systemic diseases early. Learn about the mouth-body connection and the power of salivary biomarkers. [ ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Researchers at NYU Langone Health and its Perlmutter Cancer Center have discovered that a gene-regulating molecule called ...

Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and noninvasively ...

A newly identified driver of melanoma growth not only promotes tumor blood supply but also helps tumors evade immune attack.